Aprepitant plus standard therapy prevents acute and delayed chemotherapy-induced nausea and vomiting

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.20, Iss.12, 2004-12, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting

By Ruhlmann Christina H Herrstedt Jøørn

Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. : 449-462

Informa Healthcare

Access to resources Recommend Favorite

Aprepitant: A Review of its Use in the Prevention of Chemotherapy-Induced Nausea and Vomiting

By Dando T.M. Perry C.M.

Drugs, Vol. 64, Iss. 7, 2004-01 ,pp. : 777-794

Adis International

Access to resources Recommend Favorite

Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant

By Sankhala Kamalesh K Pandya Devesh M Sarantopoulos John Soefje Scott A Giles Francis J Chawla Sant P

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1607-1614

Informa Healthcare

Access to resources Recommend Favorite

Palonosetron for chemotherapy-induced nausea and vomiting

Inpharma, Vol. 1, Iss. 1412, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Options for the Prevention and Management of Acute Chemotherapy-Induced Nausea and Vomiting in Children

By Dupuis L.L. Nathan P.C.

Pediatric Drugs, Vol. 5, Iss. 9, 2003-01 ,pp. : 597-613

Adis International

Access to resources Recommend Favorite